Danaher Co. (NYSE:DHR) Shares Bought by GenTrust LLC

GenTrust LLC grew its holdings in Danaher Co. (NYSE:DHR) by 40.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,655 shares of the conglomerate’s stock after purchasing an additional 760 shares during the period. GenTrust LLC’s holdings in Danaher were worth $739,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher during the second quarter worth about $25,000. nVerses Capital LLC acquired a new position in shares of Danaher in the 2nd quarter worth approximately $25,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Danaher during the 3rd quarter worth approximately $40,000. MFA Wealth Advisors LLC acquired a new stake in Danaher in the 2nd quarter valued at approximately $51,000. Finally, Financial Connections Group Inc. purchased a new stake in Danaher in the second quarter valued at approximately $51,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.3 %

DHR stock opened at $235.83 on Friday. The stock has a market cap of $170.34 billion, a P/E ratio of 45.01, a PEG ratio of 4.32 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a twelve month low of $215.68 and a twelve month high of $281.70. The company’s 50 day moving average is $258.15 and its two-hundred day moving average is $259.88.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the company earned $2.02 earnings per share. Research analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. Danaher’s dividend payout ratio is presently 20.61%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on DHR. Stifel Nicolaus lifted their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Raymond James cut their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Robert W. Baird dropped their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Finally, StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Monday, November 18th. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $287.16.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.